Sodium Hyaluronate
72 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
72
Total Reports
3
Deaths Reported
420.0%
Death Rate
Active Ingredients
Sodium Hyaluronate
Administration Routes
UnknownAuricular (Otic)Intra-ArticularOral
Species Affected
Unknown 49
Horse 16
Dog 7
Most Affected Breeds
Unknown 64
Schnauzer (unspecified) 5
Rottweiler 1
Thoroughbred 1
Warmblood (unspecified) 1
Most Reported Reactions
Product syringe issue 18
No sign 17
Broken components, medical device 9
Joint swelling 7
Lameness 4
Appearance, Abnormal 3
Injection site infection 3
Death by euthanasia 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Device breakage/fracture 2
Joint effusion 2
Injection site swelling 1
Outcome Breakdown
Outcome Unknown
15 (65.2%)
Recovered/Normal
5 (21.7%)
Euthanized
3 (13.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.